CAD 0.22
(10.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 3.34 Million USD | -46.57% |
2022 | 6.25 Million USD | -46.41% |
2021 | 11.68 Million USD | -7.03% |
2020 | 12.56 Million USD | 213.35% |
2019 | 2.22 Million USD | 136.46% |
2018 | -21.33 Million USD | -1653.94% |
2017 | - USD | -1097.62% |
2016 | -52.35 Thousand USD | 30.12% |
2015 | -56.96 Thousand USD | -6.92% |
2014 | -60.9 Thousand USD | 80.03% |
2013 | -338.89 Thousand USD | -182.71% |
2012 | 424.17 Thousand USD | 812.41% |
2011 | -59.54 Thousand USD | 78.18% |
2010 | -272.91 Thousand USD | -178.05% |
2009 | -98.15 Thousand USD | 41.41% |
2008 | -1.12 Million USD | -258.12% |
2007 | -49.03 Thousand USD | 77.88% |
2006 | -235.51 Thousand USD | -122.18% |
2005 | 953.56 Thousand USD | 580.68% |
2004 | -198.37 Thousand USD | -38.15% |
2003 | -143.6 Thousand USD | -135.4% |
2002 | 405.62 Thousand USD | 448.23% |
2001 | -116.48 Thousand USD | -16.57% |
2000 | -143.54 Thousand USD | 42.68% |
1999 | -174.32 Thousand USD | -176.44% |
1998 | 228.05 Thousand USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -344.4 Thousand USD | 0.0% |
2023 Q1 | 1 Million USD | 241.97% |
2023 FY | - USD | -46.57% |
2023 Q4 | 943.96 Thousand USD | 33.74% |
2023 Q3 | 705.82 Thousand USD | 2.82% |
2023 Q2 | 686.47 Thousand USD | -31.94% |
2022 Q3 | 1.82 Million USD | -7.86% |
2022 Q4 | 294.94 Thousand USD | -83.84% |
2022 FY | - USD | -46.41% |
2022 Q2 | 1.98 Million USD | -8.31% |
2022 Q1 | 2.15 Million USD | -29.25% |
2021 Q4 | 3.05 Million USD | 15.47% |
2021 FY | - USD | -7.03% |
2021 Q1 | 3.64 Million USD | -4.71% |
2021 Q2 | 3.02 Million USD | -16.95% |
2021 Q3 | 2.64 Million USD | -12.57% |
2020 FY | - USD | 213.35% |
2020 Q1 | 1.84 Million USD | 35.28% |
2020 Q2 | 2.59 Million USD | 40.35% |
2020 Q3 | 4.3 Million USD | 65.94% |
2020 Q4 | 3.82 Million USD | -11.25% |
2019 Q1 | 88.85 Thousand USD | 947.58% |
2019 Q2 | 220.06 Thousand USD | 147.66% |
2019 Q3 | 2.3 Million USD | 945.79% |
2019 FY | - USD | 136.46% |
2019 Q4 | 1.36 Million USD | -40.63% |
2018 Q1 | -860.91 Thousand USD | -241.35% |
2018 Q4 | -10.48 Thousand USD | 99.66% |
2018 Q3 | -3.07 Million USD | 56.69% |
2018 Q2 | -7.1 Million USD | -724.85% |
2018 FY | - USD | -1653.94% |
2017 Q3 | -328.41 Thousand USD | -827.52% |
2017 Q2 | -35.4 Thousand USD | -212.95% |
2017 Q1 | -11.31 Thousand USD | 16.0% |
2017 Q4 | -252.21 Thousand USD | 23.2% |
2017 FY | - USD | -1097.62% |
2016 Q4 | -13.46 Thousand USD | 0.18% |
2016 Q1 | -11.72 Thousand USD | -416.87% |
2016 Q3 | -13.49 Thousand USD | 8.92% |
2016 Q2 | -14.81 Thousand USD | -26.33% |
2016 FY | - USD | 30.12% |
2015 Q3 | -11.49 Thousand USD | 60.01% |
2015 FY | - USD | -6.92% |
2015 Q1 | -35.4 Thousand USD | -708.24% |
2015 Q2 | -28.74 Thousand USD | 18.8% |
2015 Q4 | -2268.72 USD | 80.27% |
2014 Q4 | 5820.47 USD | 132.9% |
2014 Q1 | -22.72 Thousand USD | 87.69% |
2014 Q2 | -40.44 Thousand USD | -78.02% |
2014 Q3 | -17.69 Thousand USD | 56.26% |
2014 FY | - USD | 80.03% |
2013 Q2 | 279.65 Thousand USD | 586.34% |
2013 Q1 | -57.5 Thousand USD | -111.08% |
2013 Q3 | -13.65 Thousand USD | -104.88% |
2013 Q4 | -184.54 Thousand USD | -1251.74% |
2013 FY | - USD | -182.71% |
2012 Q1 | -6609.87 USD | 89.79% |
2012 FY | - USD | 812.41% |
2012 Q4 | 518.84 Thousand USD | 1290.64% |
2012 Q2 | -44.5 Thousand USD | -573.39% |
2012 Q3 | -43.57 Thousand USD | 2.1% |
2011 FY | - USD | 78.18% |
2011 Q1 | 17.99 Thousand USD | 111.69% |
2011 Q2 | -2781.97 USD | -115.46% |
2011 Q3 | -9257.25 USD | -232.76% |
2011 Q4 | -64.72 Thousand USD | -599.17% |
2010 Q2 | -63.24 Thousand USD | -0.67% |
2010 Q3 | 6854.93 USD | 110.84% |
2010 Q4 | -153.93 Thousand USD | -2345.67% |
2010 FY | - USD | -178.05% |
2010 Q1 | -62.82 Thousand USD | 88.39% |
2009 Q2 | -9856.49 USD | 28.69% |
2009 FY | - USD | 41.41% |
2009 Q4 | -541.3 Thousand USD | -1553.03% |
2009 Q1 | -13.82 Thousand USD | 98.81% |
2009 Q3 | -32.74 Thousand USD | -232.23% |
2008 FY | - USD | -258.12% |
2008 Q4 | -1.15 Million USD | -5857.28% |
2008 Q3 | 20.12 Thousand USD | 51.8% |
2008 Q2 | 13.25 Thousand USD | 1267.55% |
2008 Q1 | 969.32 USD | 101.52% |
2007 Q2 | -4051.08 USD | 59.96% |
2007 Q4 | -63.56 Thousand USD | -1832.09% |
2007 Q3 | 3670.12 USD | 190.6% |
2007 FY | - USD | 77.88% |
2007 Q1 | -10.11 Thousand USD | 92.18% |
2006 Q3 | -12.17 Thousand USD | 87.5% |
2006 Q2 | -97.36 Thousand USD | -446.06% |
2006 Q1 | -17.83 Thousand USD | 69.15% |
2006 FY | - USD | -122.18% |
2006 Q4 | -129.35 Thousand USD | -962.76% |
2005 Q4 | -57.79 Thousand USD | -184.18% |
2005 Q3 | -20.33 Thousand USD | 51.88% |
2005 Q2 | -42.26 Thousand USD | -15.4% |
2005 Q1 | -36.62 Thousand USD | 50.89% |
2005 FY | - USD | 580.68% |
2004 Q4 | -74.57 Thousand USD | -41.46% |
2004 Q1 | -22.93 Thousand USD | 72.03% |
2004 Q2 | -27.46 Thousand USD | -19.75% |
2004 FY | - USD | -38.15% |
2004 Q3 | -52.71 Thousand USD | -91.92% |
2003 Q1 | -23.67 Thousand USD | 18.83% |
2003 Q2 | -24.35 Thousand USD | -2.85% |
2003 Q3 | -24.7 Thousand USD | -1.44% |
2003 FY | - USD | -135.4% |
2003 Q4 | -82.02 Thousand USD | -232.02% |
2002 Q2 | -21.62 Thousand USD | 14.91% |
2002 Q1 | -25.41 Thousand USD | 6.87% |
2002 FY | - USD | 448.23% |
2002 Q4 | -29.17 Thousand USD | 5.86% |
2002 Q3 | -30.98 Thousand USD | -43.32% |
2001 FY | - USD | -16.57% |
2001 Q4 | -27.28 Thousand USD | -29.41% |
2001 Q3 | -21.08 Thousand USD | 55.56% |
2001 Q2 | -47.44 Thousand USD | -87.39% |
2001 Q1 | -25.31 Thousand USD | 33.69% |
2000 Q4 | -38.18 Thousand USD | -15.86% |
2000 Q3 | -32.95 Thousand USD | 36.66% |
2000 FY | - USD | 42.68% |
2000 Q1 | -20.46 Thousand USD | 57.79% |
2000 Q2 | -52.03 Thousand USD | -154.18% |
1999 Q4 | -48.49 Thousand USD | 25.44% |
1999 Q2 | -33.83 Thousand USD | -28.11% |
1999 FY | - USD | -176.44% |
1999 Q1 | -26.4 Thousand USD | 0.0% |
1999 Q3 | -65.03 Thousand USD | -92.24% |
1998 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Aion Therapeutic Inc. | -6.07 Million CAD | 155.072% |
Ayurcann Holdings Corp. | -2.01 Million CAD | 266.372% |
Blueberries Medical Corp. | -1.22 Million CAD | 373.77% |
The BC Bud Corporation | -1.19 Million CAD | 379.67% |
BioNxt Solutions Inc. | -6.48 Million CAD | 151.582% |
CordovaCann Corp. | -1.6 Million CAD | 308.714% |
Christina Lake Cannabis Corp. | -2.62 Million CAD | 227.5% |
Captor Capital Corp. | 2.42 Million CAD | -38.152% |
City View Green Holdings Inc. | -2.01 Million CAD | 266.044% |
1CM Inc. | 1.31 Million CAD | -154.65% |
Global Hemp Group Inc. | -24.79 Thousand CAD | 13591.28% |
Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | 251.463% |
IM Cannabis Corp. | -2.79 Million CAD | 219.889% |
Lobe Sciences Ltd. | -4.4 Million CAD | 175.981% |
Maple Leaf Green World Inc. | -392.21 Thousand CAD | 952.819% |
Mountain Valley MD Holdings Inc. | -3.19 Million CAD | 204.757% |
Nextleaf Solutions Ltd. | 1.14 Million CAD | -193.0% |
Ovation Science Inc. | -778.83 Thousand CAD | 529.476% |
Pharmadrug Inc. | -1.33 Million CAD | 350.551% |
Captiva Verde Wellness Corp. | -6.05 Million CAD | 155.232% |
RAMM Pharma Corp. | -6.3 Million CAD | 153.076% |
RIV Capital Inc. | -20.28 Million CAD | 116.493% |
Revive Therapeutics Ltd. | -5.59 Million CAD | 159.784% |
Red White & Bloom Brands Inc. | -77.59 Million CAD | 104.311% |
SLANG Worldwide Inc. | -2.95 Million CAD | 213.359% |
1933 Industries Inc. | -10.03 Million CAD | 133.339% |
Red Light Holland Corp. | -5.25 Million CAD | 163.641% |
Top Strike Resources Corp. | -767.99 Thousand CAD | 535.537% |
Xebra Brands Ltd. | -1.49 Million CAD | 323.739% |
Adastra Holdings Ltd. | -1.41 Million CAD | 337.014% |